Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Neurocrine Biosciences Exercises Option to License Rare Pediatric Epilepsy Treatment

americanpharmaceuticalreviewMay 18, 2020

Tag: Neurocrine Biosciences , Pediatric Epilepsy , ACT-709478

PharmaSources Customer Service